596
Views
2
CrossRef citations to date
0
Altmetric
Review

PARP inhibitors for homologous recombination-deficient prostate cancer

&
Pages 123-133 | Received 10 Oct 2017, Accepted 28 Mar 2018, Published online: 04 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jian Hu, Peihe Liang, Dachun Jin, Runze Fan, Xiaodu Xie, Chuan Liu, Qing Jiang & Liang Gao. (2022) Poly (ADP-ribose) polymerase inhibitors (PARPi) for advanced malignancies with multiple DNA-repair genetic aberrations. Expert Review of Anticancer Therapy 22:7, pages 717-723.
Read now
Jarosław Przybycinski, Magdalena Nalewajska, Małgorzata Marchelek-Mysliwiec, Violetta Dziedziejko & Andrzej Pawlik. (2019) Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers. Expert Opinion on Therapeutic Targets 23:9, pages 773-785.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.